News & Updates

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

Individuals hospitalized for COVID-19 vs seasonal influenza face a greater risk of cognitive impairment and fatigue but a lower risk of cardiac disorders as long-term consequences of infection, according to a retrospective population-based cohort study in Singapore.

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

11 hours ago

Wildfire smoke exposure ups risk of heart failure in older adults

a day ago

Exposure to wildfire smoke for an extended period may increase the risk of heart failure (HF) in older adults, particularly women and socially vulnerable populations, suggests a study.

Wildfire smoke exposure ups risk of heart failure in older adults

a day ago

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

Symptoms for ARIs in children vary across age groups

01 Jul 2025

Acute respiratory infections (ARIs) are associated with various symptoms across different age groups, according to a Korea study.

Symptoms for ARIs in children vary across age groups

01 Jul 2025

MMP7 predicts progression, death in antifibrotic-treated IPF

28 Jun 2025 by

Higher levels of matrix metalloprotease 7 (MMP7) pretreatment are predictive of 12-month progression and mortality among patients with idiopathic pulmonary fibrosis (IPF) who have been treated with antifibrotics, reveals a recent study.

MMP7 predicts progression, death in antifibrotic-treated IPF

28 Jun 2025

Ibrexafungerp expands salvage antifungal treatment options as a pill

25 Jun 2025 by

For patients with fungal diseases that preclude receiving standard treatment or IV antifungals primarily due to refractoriness or resistance, ibrexafungerp can serve as an effective salvage treatment given orally, offering a positive risk-benefit ratio up to the final data cut-off in the FURI trial

Ibrexafungerp expands salvage antifungal treatment options as a pill

25 Jun 2025

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

New drug applications approved by US FDA as of 16-31 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

In the treatment of adults with acute, uncomplicated influenza infections, onradivir appears to provide similar curative efficacy as oseltamivir while having an acceptable safety profile, as shown in a phase III study.

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

21 Jun 2025 by

Hypoglossal nerve stimulation is safe and effective for reducing apnoea-hypopnoea index (AHI) in Asian patients with obstructive sleep apnoea (OSA), according to early experience from a single tertiary Singaporean sleep centre.

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

21 Jun 2025

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025 by

The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

More cognitive issues, fewer heart problems after COVID-19 vs flu hospitalization in Asians

Wildfire smoke exposure ups risk of heart failure in older adults

Wildfire smoke exposure ups risk of heart failure in older adults

Short-course antibiotic for paediatric CAP on par with long-course regimen

Short-course antibiotic for paediatric CAP on par with long-course regimen

Symptoms for ARIs in children vary across age groups

Symptoms for ARIs in children vary across age groups

MMP7 predicts progression, death in antifibrotic-treated IPF

MMP7 predicts progression, death in antifibrotic-treated IPF

Ibrexafungerp expands salvage antifungal treatment options as a pill

Ibrexafungerp expands salvage antifungal treatment options as a pill

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Onradivir as good as oseltamivir for acute, uncomplicated flu

Onradivir as good as oseltamivir for acute, uncomplicated flu

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis